This House resolution, introduced October 31, 2025, expresses support for the United States role in helping save children's lives and protect health in low-income countries by using Gavi, the Vaccine Alliance. The resolution lists Gavi's work since 2000, including supporting immunization in 78 countries, helping immunize more than 1,100,000,000 additional children, and estimating 18,800,000 deaths averted from 2000–2023. The resolution highlights Gavi's market-shaping work (lowering vaccine prices and increasing suppliers), support for new vaccines including malaria vaccines, contributions to COVAX COVID-19 vaccine deliveries, and efforts to strengthen health systems and cold-chain capacity. It calls for continued U.S. support, encourages use of Department of State and CDC global immunization resources, urges multiyear U.S. pledges, and encourages increased U.S. investment for Gavi's 2026–2030 strategic period.
This resolution is a nonbinding statement of the House's position. It does not itself create new programs or spend money. It shows Congressional support for using Gavi to expand vaccine access in low-income countries and asks for steady, multiyear U.S. commitments. If followed by funding or pledges, that funding would be decided in later appropriations or budget actions. The resolution says U.S. support for Gavi can help prevent outbreaks abroad and support global health security.
The resolution does not authorize specific federal spending or appropriate funds. No publicly available information on exact new U.S. costs appears in the resolution text. The resolution encourages increased U.S. commitment and multiyear pledges for Gavi in 2026–2030, but it does not specify dollar amounts or funding sources. The text does include past figures: Gavi-supported countries contributed more than $1,700,000,000 to immunization campaigns between 2008 and 2023 and the resolution states Gavi had contributed $250,000,000,000 in economic benefits as of 2023 and a claimed $54 return for every $1 invested.
Supporters say Gavi has expanded access to new and routine vaccines, reduced child deaths from vaccine-preventable diseases, made vaccines more affordable and reliable, helped deliver COVID-19 vaccines through COVAX, and supported introduction of malaria and other vaccines. The resolution presents Gavi as cost-effective, country-led, and important for global and U.S. health security. It argues multiyear U.S. pledges help Gavi plan and leverage other donor funding.
No publicly available information on opponents' views is included in the resolution text.